Earnings - 5th Sept 2008

8:11AM Nokia mobile device market share outlook follow-up (NOK) 22.31 : As mentioned at 8:03, Nokia lowers its Q3 2008 mobile device market share outlook. Co now expects its mobile device market share in Q3 2008 to be lower than in Q2 2008. This compares to Nokia's earlier estimation provided in Q2 results announcement, when the co said it expected its mobile device market share in Q3 2008 to be approximately at the same level sequentially. Nokia continues to target an increase in its market share in mobile devices for the full year 2008. Nokia expects the overall mobile device market in 2008 to be impacted by the weaker consumer confidence in multiple markets. However, Nokia continues to expect industry mobile device volumes in 2008 to grow 10% or more from the ~1.14 bln units Nokia estimated for 2007. Nokia also continues to expect industry mobile device volumes in Q3 2008 to be up sequentially... Nokia's current estimate that its mobile device market share in the third quarter 2008 will be lower than previously expected is due to multiple factors. These factors include Nokia's tactical decision to not meet certain aggressive pricing of some competitors, the overall market competition, including the entry markets, and the temporary impact of a slower ramp-up of a mid-range Nokia device. Nokia's strategy is to take market share only when the company believes it to be sustainably profitable in the longer term. Nokia has not broadly participated in the recent aggressive pricing activity - as it believes that the negative impact to profitability would outweigh any short term incremental benefits to device unit sales.

7:55AM Aceto beats single analyst estimate by $0.13; revs increase 20.1% y/y (ACET) 8.51 : Reports Q4 earnings of $0.32, $0.13 better than the single analyst estimate of $0.19; revenues rose 20.1% year/year to $104.7 mln (no estimate). Co states, "As we look to expand Aceto's global markets and grow our core businesses, we look to move into marketplaces which appear to be attractive for our business model. One such opportunity is Vietnam where we have been granted a license to sell medicines, medical devices and active pharmaceutical ingredients to the pharmaceutical industry..."

12:01AM Nalco updates guidance (NLC) 22.35 : Co announces goals for FY08 remain 8% adjusted EBITDA growth, a 35% increase in diluted EPS, free cash flow in the high $200 mln range, and cost savings of $75 mln. Co expects strong single-digit, real sales growth, but has slightly adjusted earnings expectations. Chief Financial Officer expects high single-digit EBITDA increases as they make targeted investments to accelerate growth, with a medium-term return to double-digit EBITDA growth targets as sales accelerate from these investments. "We won't have specific 2009 goals to announce until February but we don't expect our EBITDA target to stray far from this year's 8% growth goal," CFO Bradley J. Bell added.